Delivery Order SPE2DB20D1004-SPE2DB21FE8Z3
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current Delivery Order, valued at $3,318.24, is for "PRIME VENDOR PHARM...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order, valued at $86,034.28, is...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00 and running through November 2026, enables the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific delivery order, valued at $1,770.24,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order, valued at $1,768.80, is for "PRIME VENDOR PHARM...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order valued at $1,225.30 issued by the Defense Logistics Agency (DLA). The award falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications,...
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,060.37 delivery order was awarded by the Defense Logistics Agency (DLA) for the "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" requirement, which indicates the provision of a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and other federal healthcare programs....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $2,916.35 for "Prime Vendor Pharm Branch-Philadelphia" under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award is for a Delivery Order valued at $2,757.44, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract is for a "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" to provide a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,314.32 for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The award has no set-aside designation, indicating open competition. The contract covers the delivery of a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical valued at up to $999,999,999.00. The contract covers the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, over-the-counter medications, and critical care materials such as...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB21FE8Z3Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order, valued at $6,833.82, is for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" and has no set-aside designation, indicating full and open competition. The delivery order covers the supply of various pharmaceutical products, including specialty medications, generic drugs, brand-name pharmaceuticals, and medical devices, to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract has an ultimate completion date of December 2, 2020.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 12/1/20 |